Stock HPC THE HYDRATION PHARMACEUTICALS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company The Hydration Pharmaceuticals Company Limited

Equities

HPC

AU0000187957

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 02:10:18 2024-05-24 EDT 		5-day change 1st Jan Change
0.013 AUD 0.00% Intraday chart for The Hydration Pharmaceuticals Company Limited 0.00% -45.83%
05-24 The Hydration Pharmaceuticals Postpones Managing Director Appointment MT
05-24 The Hydration Pharmaceuticals Company Limited Announces Board Change, Effective 25 May 2024 CI

Business Summary

The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Hydralyte
100.0 %
9 100.0 % 10 100.0 % +10.34%

Sales per region

AUD in Million2022Weight2023Weight Delta
Canada
57.2 %
5 50.5 % 6 57.2 % +24.80%
United States
42.8 %
5 49.5 % 4 42.8 % -4.44%

Managers

Managers TitleAgeSince
Oliver Baker CEO
 Chief Executive Officer - 17-12-31
Chris Kavanaugh DFI
 Director of Finance/CFO - 18-04-30
Victoria Nadalin SEC
 Corporate Secretary - 23-02-07

Members of the board

Members of the board TitleAgeSince
Margaret Hardin BRD
 Director/Board Member 51 22-02-07
Adem Karafili BRD
 Director/Board Member - 18-10-14
George Livery CHM
 Chairman - 21-11-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 265,141,804 223,688,259 ( 84.37 %) 0 84.37 %

Shareholders

NameEquities%Valuation
PURE Asset Management Pty Ltd.
22.99 %
60,952,123 22.99 % 474 817 $
Regal Funds Management Pty Ltd.
10.45 %
27,702,067 10.45 % 215 799 $
Radek Sali
4.791 %
12,702,908 4.791 % 98 956 $
Paul Orlin
1.279 %
3,392,272 1.279 % 26 426 $
FF Investments NZ Ltd.
1.129 %
2,992,992 1.129 % 23 315 $
Gowing Bros. Ltd. (Investment Management)
1.117 %
2,960,529 1.117 % 23 063 $
Adem Karafili
0.9850 %
2,611,614 0.9850 % 20 344 $
343 Pty Ltd.
0.9726 %
2,578,865 0.9726 % 20 089 $
Tahmedia Pty Ltd.
0.9035 %
2,395,667 0.9035 % 18 662 $
Richjac Pty Ltd.
0.7171 %
1,901,411 0.7171 % 14 812 $

Company contact information

The Hydration Pharmaceuticals Co. Ltd.

Level 42 Rialto South Tower

3000, Melbourne

+

address The Hydration Pharmaceuticals Company Limited(HPC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED Stock The Hydration Pharmaceuticals Company Limited
-45.83% 2.28M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 728B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.05% 603B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.23% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.78% 332B
ABBVIE INC. Stock AbbVie Inc.
+1.35% 279B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 244B
NOVARTIS AG Stock Novartis AG
+8.09% 207B
ROCHE HOLDING AG Stock Roche Holding AG
-5.77% 205B
AMGEN INC. Stock Amgen Inc.
+6.19% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HPC Stock
  4. Company The Hydration Pharmaceuticals Company Limited